Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BrainStorm Announces Positive Topline Data in NurOwn Study for Progressive MS

americanpharmaceuticalreviewMarch 30, 2021

Tag: BrainStorm , NurOwn , MS , MSWS-12 , T25FW

PharmaSources Customer Service